4//SEC Filing
Mills Kenneth T. 4
Accession 0001562180-24-005798
CIK 0001590877other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 5:05 PM ET
Size
14.7 KB
Accession
0001562180-24-005798
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Mills Kenneth T.
Director
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2024-07-17−2,210→ 78,944 totalExercise: $3.76Exp: 2025-05-19→ Common Stock (2,210 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2024-07-16−200→ 81,154 totalExercise: $3.76Exp: 2025-05-19→ Common Stock (200 underlying) - Sale
Common Stock
2024-07-16$13.76/sh−200$2,752→ 408,035 total - Exercise/Conversion
Common Stock
2024-07-16$3.76/sh+200$752→ 408,235 total - Exercise/Conversion
Common Stock
2024-07-17$3.76/sh+2,210$8,310→ 410,245 total - Sale
Common Stock
2024-07-17$13.77/sh−2,210$30,440→ 408,035 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $13.76 to $13.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001652824
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 5:05 PM ET
- Size
- 14.7 KB